Following publication of the Research Article by Jin Li, Ruihua Xu, Shukui Qin, Tianshu Liu, Hongming Pan, Jianming Xu, Feng Bi, Robert Lim, Suzhan Zhang, Yi Ba, Yuxian Bai, Nanfeng Fan, Akihito Tsuji, Kun-Huei Yeh, Brigette Ma, Vivian Wei, Dongmei Shi, Emmanuelle Magherini & Lin Shen, titled ‘Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study’, which appeared in the August 2018 issue of Future Oncology (Future Oncology [Lond.] 14[20], 2031–2044 [2018]; DOI: 10.2217/fon-2017-0669), it has been brought to our attention that Table 2 has been corrected as follows:
‘No’ and ‘yes’ have been swapped, and now correspond to the correct values in Table 2. The original table was printed as:
The corrected table now reads:
The authors and editors of Future Oncology would like to sincerely apologise for any confusion or inconvenience this may have caused our readers.